CSPC Pharmaceutical Group Limited — Earnings Release 2001

Sep 21, 2001

Listed Company Information

CHINA PHARMA<01093> - Results Announcement (Summary) China Pharmaceutical Enterprise and Investment Corporation Limited announced on 21/9/2001: (stock codes: Ord: 1093 & War: 837) Year end date: 31/12/2001 Currency: HKD (Unaudited) (Unaudited) Last Current Corresponding Period Period from 1/1/2001 from 1/1/2000 to 30/6/2001 to 30/6/2000 Turnover : 570,627,000 494,195,000 Profit/(Loss) from Operations : 85,194,000 93,371,000 Finance cost : (13,313,000) (15,799,000) Share of Profit/(Loss) of Associates : - - Share of Profit/(Loss) of Jointly Controlled Entities : 2,843,000 3,171,000 Profit/(Loss) after Tax & MI : 60,392,000 70,630,000 % Change over Last Period : -14.5% EPS/(LPS)-Basic : 4.87 cents 5.69 cents -Diluted : 4.82 cents 5.62 cents Extraordinary (ETD) Gain/(Loss) : - - Profit/(Loss) after ETD Items : 60,392,000 70,630,000 Interim Dividend per Share : Nil Nil (Specify if with other options) : - - B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for Current Period : - B/C Dates for Other Distribution : N/A Remarks: 1. Profit from operations For the six months ended 6.30. 2001 2000 HK$ HK$ Profit from operations has been arrived at after charging (crediting): Goodwill written off on impairment of an associate 2,032,000 - Provision for bad and doubtful debts 4,027,000 - Provision for impairment loss on property, plant and equipment 1,000,000 - Gain on disposal of subsidiaries (3,860,000) - ======== ======== 2. Earnings per share The calculation of the basic and diluted earnings per share is based on the following data: For the six months ended 6.30. 2001 2000 Profit attributable to shareholders HK$60,392,000 HK$70,630,000 ============ ============ Weighted average number of ordinary shares for the purpose of basic earnings per share 1,240,447,279 1,240,411,126 Effect of dilutive potential ordinary share in respect of share options 13,068,182 15,295,455 ------------------------------ Weighted average number of ordinary shares for the purpose of diluted earnings per share 1,253,515,461 1,255,706,581 ============ ============ The computation of diluted earnings per share does not assume the exercise of the Company's outstanding warrants as the exercise price is higher than the fair value per share during the period.